OBJECTIVE: To assess the annual costs of rheumatoid arthritis (RA) patients attended at rheumatology units in Spanish public hospitals. METHODS: A longitudinal, prospective, multicenter, observational, 1-year study was performed in the rheumatology units of randomly selected Spanish public hospitals. Randomly selected RA patients were included. The patients made four visits (at baseline and every 4 months). Resource use and costs were collected from patient diaries and structured questionnaires. RESULTS: A total of 301 patients were included and 190 (83% women) completed the study. The mean (± SD) age was 59±13 years and the mean disease duration was 10±10 years. The median annual cost per patient was 3,845 euros (318-36,783). The estimated total annual cost of the Spanish RA population managed in the rheumatology units of public hospitals was 590,110,000 euros. Of total costs, 74% were direct costs and 26% were indirect costs. Medical costs represented 81% of direct costs. The main components of medical costs were drugs (56%), medical visits (21%), complementary tests (12%), and hospitalizations (11%). Permanent work disability represented 66% of indirect costs. CONCLUSIONS: Direct costs were substantially higher than indirect costs. The main components of medical costs were drugs. There was high variability in resource use with a wide range of annual costs per patient.
OBJECTIVE: To assess the annual costs of rheumatoid arthritis (RA) patients attended at rheumatology units in Spanish public hospitals. METHODS: A longitudinal, prospective, multicenter, observational, 1-year study was performed in the rheumatology units of randomly selected Spanish public hospitals. Randomly selected RApatients were included. The patients made four visits (at baseline and every 4 months). Resource use and costs were collected from patient diaries and structured questionnaires. RESULTS: A total of 301 patients were included and 190 (83% women) completed the study. The mean (± SD) age was 59±13 years and the mean disease duration was 10±10 years. The median annual cost per patient was 3,845 euros (318-36,783). The estimated total annual cost of the Spanish RA population managed in the rheumatology units of public hospitals was 590,110,000 euros. Of total costs, 74% were direct costs and 26% were indirect costs. Medical costs represented 81% of direct costs. The main components of medical costs were drugs (56%), medical visits (21%), complementary tests (12%), and hospitalizations (11%). Permanent work disability represented 66% of indirect costs. CONCLUSIONS: Direct costs were substantially higher than indirect costs. The main components of medical costs were drugs. There was high variability in resource use with a wide range of annual costs per patient.
Authors: M Cárdenas; S de la Fuente; M C Castro-Villegas; M Romero-Gómez; D Ruiz-Vílchez; J Calvo-Gutiérrez; A Escudero-Contreras; J R Del Prado; E Collantes-Estévez; P Font Journal: Rheumatol Int Date: 2016-10-24 Impact factor: 2.631
Authors: R Lopez-Gonzalez; D Seoane-Mato; S Perez-Vicente; M A Martin-Martinez; F Sanchez-Alonso; L Silva-Fernandez Journal: Rheumatol Int Date: 2016-08-18 Impact factor: 2.631
Authors: Antonio Gomez-Centeno; Esteban Rubio-Romero; Juan Gabriel Ovalles; Sara Manrique-Arija; Sara Marsal-Barril; Juan Amarelo-Ramos; Javier Del Pino-Montes; Santiago Muñoz-Fernández; Sagrario Bustabad; Ceferino Barbazán-Álvarez Journal: Rheumatol Int Date: 2019-08-08 Impact factor: 2.631
Authors: M Cárdenas; S de la Fuente; P Font; M C Castro-Villegas; M Romero-Gómez; D Ruiz-Vílchez; J Calvo-Gutiérez; A Escudero-Contreras; M A Casado; J R Del Prado; E Collantes-Estévez Journal: Rheumatol Int Date: 2016-02 Impact factor: 2.631
Authors: Mario Gil-Conesa; Juan Antonio Del-Moral-Luque; Ruth Gil-Prieto; Ángel Gil-de-Miguel; Ramón Mazzuccheli-Esteban; Gil Rodríguez-Caravaca Journal: BMC Health Serv Res Date: 2020-05-04 Impact factor: 2.655